FLU A/B (Influenza A/B)

Influenza, commonly known as the flu, is a highly contagious respiratory infection caused by influenza viruses. It typically leads to symptoms such as fever, chills, cough, sore throat, muscle aches, and fatigue. While many individuals experience mild symptoms and recover without complications, the flu can lead to severe health issues such as pneumonia, bronchitis, and exacerbation of underlying conditions, particularly for high-risk groups. These high-risk groups include infants, elderly individuals, pregnant women, and those with chronic health conditions like asthma, diabetes, or heart disease. Timely diagnosis and treatment are crucial to prevent complications and reduce the spread of the virus.

The FLU A/B Rapid Antigen Test is a simple and effective tool designed to quickly detect the presence of Influenza A and Influenza B viral antigens from nasal or throat swab samples. This immunochromatographic assay is ideal for use in clinical and point-of-care settings, offering fast and reliable results. Within 10-15 minutes, the test provides a qualitative result, enabling healthcare providers to confirm the presence of the influenza virus. If the test returns a positive result, it allows for the immediate initiation of appropriate antiviral treatment, helping to manage symptoms and prevent further transmission.

One of the major advantages of the FLU A/B Rapid Antigen Test is its ability to simultaneously detect both Influenza A and Influenza B infections. This is particularly important as both strains of the virus circulate widely during flu season, and early identification helps differentiate between different viral causes of respiratory illness. The test is designed to be user-friendly and highly sensitive, providing accurate results even in the early stages of infection when symptoms first appear.

By offering rapid detection, the FLU A/B Rapid Antigen Test plays a critical role in managing flu outbreaks, reducing the burden on healthcare systems, and ensuring that infected individuals receive the care they need without unnecessary delays. Fast testing also helps prevent unnecessary use of antibiotics, as influenza is caused by a virus and requires antiviral treatment, not antibiotics. As a result, this test is an invaluable tool for both diagnosis and effective management of influenza infections in various healthcare settings.

Sample types: nasopharyngeal and oropharyngeal swabs

Sensitivity: 97 %

Specificity: 99%

LoD: 250 CFU/mL

Q-Check Flu A/B Rapid Antigen Test                        25T/Box                               QCH-0023-25

                                                                            Single Test/Box                    QCH-0023-1